The prion-like propagation hypothesis proposes that misfolded protein aggregates characteristic of neurodegenerative diseases—including amyloid-beta (Aβ) and tau in Alzheimer's disease (AD), alpha-synuclein in Parkinson's disease (PD), and TDP-43 in amyotrophic lateral sclerosis (FTD/ALS)—spread between neurons through a template-dependent mechanism analogous to prion protein propagation. This intercellular transmission of pathological protein conformations provides a mechanistic explanation for the progressive spread of neurodegeneration through anatomically connected brain networks.
The fundamental premise is that pathological protein aggregates can induce conformational conversion of their normal counterparts in recipient cells, creating a self-propagating cycle of pathology spread that drives disease progression from initial sites of vulnerability to connected brain regions.[@prusiner2017]
The template-dependent seeding mechanism relies on the ability of misfolded proteins to serve as conformational templates for normal proteins.[@walker2016] Pathological aggregates adopt stable beta-sheet rich conformations that can interact with normal proteins, inducing them to adopt the same pathological structure. This conversion process involves:
The prion-like propagation hypothesis proposes that misfolded protein aggregates characteristic of neurodegenerative diseases—including amyloid-beta (Aβ) and tau in Alzheimer's disease (AD), alpha-synuclein in Parkinson's disease (PD), and TDP-43 in amyotrophic lateral sclerosis (FTD/ALS)—spread between neurons through a template-dependent mechanism analogous to prion protein propagation. This intercellular transmission of pathological protein conformations provides a mechanistic explanation for the progressive spread of neurodegeneration through anatomically connected brain networks.
The fundamental premise is that pathological protein aggregates can induce conformational conversion of their normal counterparts in recipient cells, creating a self-propagating cycle of pathology spread that drives disease progression from initial sites of vulnerability to connected brain regions.[@prusiner2017]
The template-dependent seeding mechanism relies on the ability of misfolded proteins to serve as conformational templates for normal proteins.[@walker2016] Pathological aggregates adopt stable beta-sheet rich conformations that can interact with normal proteins, inducing them to adopt the same pathological structure. This conversion process involves:
This mechanism is fundamentally similar to prion propagation, where the PrP^Sc isoform templates conversion of normal PrP^C. However, in neurodegenerative diseases, the pathological proteins are not considered infectious under normal circumstances—the key difference being the efficiency and route of transmission.
Like prion proteins, disease-associated proteins can exist in multiple conformational variants ("strains") that differ in their biological properties. Different strains exhibit:
Animal studies provide strong evidence for prion-like propagation:
Tau propagation studies:
Tau PET imaging in humans reveals propagation patterns that follow functional brain networks. Regions with strong connectivity to early tau accumulation show subsequent tau deposition, consistent with network-mediated spread. This pattern supports the hypothesis that tau pathology spreads along neural networks.
The Braak staging system for Parkinson's disease demonstrates that alpha-synuclein pathology progresses in a predictable pattern through anatomically connected regions, from the olfactory bulb and enteric nervous system to the brainstem and eventually the cortex. This progressive pattern is consistent with propagation along neural pathways.
Pathological proteins can be released from cells through multiple mechanisms:
| Mechanism | Description | Evidence |
|-----------|-------------|----------|
| Cell death | Lysis releases intracellular aggregates | Detected in CSF after neuronal loss |
| Exosomes | Protected vesicles containing pathological proteins | Aβ, alpha-synuclein, tau in exosomes |
| Synaptic release | Activity-dependent release at synapses | Synaptic activity promotes release |
| Tunneling nanotubes | Direct cell-to-cell connections | Observed in cell culture |
Recipient cells can acquire pathological proteins through:
Once internalized, seeds must reach appropriate cellular compartments to template conversion. This involves:
The spread of pathology follows anatomical connections between neurons:
The progression follows established neural pathways:
Functional brain networks mediate propagation:
The propagation pathway offers multiple therapeutic targets:
Antibodies against pathological proteins are in clinical development:
Aggregation inhibitors under investigation include:
Prion-like propagation interacts with neuroinflammatory processes:
Cellular clearance systems are relevant:
Neural activity influences propagation:
CSF biomarkers may reflect propagation activity:
PET ligands allow visualization of pathology in vivo:
The prion-like propagation hypothesis provides a compelling framework for understanding how neurodegeneration spreads through the brain. By demonstrating that pathological proteins can transfer between cells and template further aggregation, this mechanism explains the progressive nature of these diseases and identifies multiple potential therapeutic targets. While challenges remain in translating this understanding into effective treatments, the hypothesis has fundamentally changed our approach to neurodegenerative disease research and therapy development.
The glymphatic system plays a critical role in the clearance of extracellular pathological proteins, directly influencing prion-like propagation. This macroscopic waste clearance network operates through perivascular pathways that facilitate cerebrospinal fluid (CSF) exchange with interstitial fluid. When glymphatic function declines, extracellular aggregates accumulate, increasing the material available for intercellular transmission.
The glymphatic system efficiently clears soluble Aβ, tau, and alpha-synuclein monomers and small oligomers under normal conditions. Age-related decline in glymphatic function correlates with increased protein aggregation in both Alzheimer's and Parkinson's diseases. AQP4 water channel polarization at astrocytic endfeet drives perivascular CSF flow; dysfunction in this system significantly reduces clearance capacity.
Studies using DTI-ALPS (Diffusion Tensor Image Analysis Along the Perivascular Space) index show reduced glymphatic function in Parkinson's disease patients compared to controls. This impairment correlates with disease severity and is particularly pronounced in regions with early alpha-synuclein deposition.
The relationship between glymphatic clearance and prion-like propagation is bidirectional:
This creates a positive feedback loop: initial propagation damages glymphatic function, reduced clearance increases propagation material, accelerating disease progression.
Enhancing glymphatic function represents a complementary approach to blocking propagation:
The amyloid hypothesis originally proposed Aβ as the initiating event, with tau pathology developing subsequently. However, prion-like propagation suggests a more complex relationship where both proteins can spread independently while influencing each other.
Tau propagation follows Braak staging in Alzheimer's disease, advancing from entorhinal cortex through hippocampal formation to neocortex. PET imaging using tau ligands demonstrates that regions with strong functional connectivity to early tau deposition show subsequent accumulation, supporting network-mediated spread.
Aβ may accelerate tau propagation by:
Alpha-synuclein pathology progresses through six stages in PD (Braak staging), beginning in the olfactory bulb and enteric nervous system, advancing to the dorsal motor nucleus of the vagus, then to the substantia nigra and ultimately the cortex. This pattern is consistent with propagation along neural pathways.
Importantly, not all alpha-synucleinopathies show the same propagation pattern. Dementia with Lewy bodies shows more diffuse cortical involvement compared to PD, suggesting different strains or propagation mechanisms.
TDP-43 pathology in FTD and ALS follows patterns distinct from other proteinopathies. In ALS, TDP-43 inclusions involve upper and lower motor neurons, while FTD shows predominant frontotemporal involvement.
Recent evidence suggests TDP-43 can propagate between cells, though the efficiency appears lower than Aβ or tau. The relationship between TDP-43 propagation and the c9orf72 hexanucleotide repeat expansion (the most common genetic cause of FTD/ALS) remains an active area of investigation.
Like prions, neurodegenerative disease proteins exhibit conformational polymorphism:
Strain diversity may explain: